Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.00 (-0.29%)
Close on Nov 13, 2026Market cap $5.65MP/E –Yield –
Tempest Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Tempest Therapeutics's total assets was $8.76M at Sep 30, 2026. For fiscal 2025 it was $16.93M, down 59.2% from the year before. Over ten years it grew -19.0% a year on average. The highest annual figure on record is $138.61M in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.93M | -59.2% |
| FY2024 | Dec 31, 2024 | $41.49M | -19.6% |
| FY2023 | Dec 31, 2023 | $51.60M | +12.0% |
| FY2022 | Dec 31, 2022 | $46.09M | -37.1% |
| FY2021 | Dec 31, 2021 | $73.24M | +220.3% |
| FY2020 | Dec 31, 2020 | $22.86M | -69.5% |
| FY2019 | Dec 31, 2019 | $74.97M | -10.8% |
| FY2018 | Dec 31, 2018 | $84.07M | +324.4% |
| FY2017 | Dec 31, 2017 | $19.81M | -83.8% |
| FY2016 | Dec 31, 2016 | $122.54M | -11.6% |
| FY2015 | Dec 31, 2015 | $138.61M | +111.4% |
| FY2014 | Dec 31, 2014 | $65.57M | +37.9% |
| FY2013 | Dec 31, 2013 | $47.55M | +44.9% |
| FY2012 | Dec 31, 2012 | $32.81M | +615.7% |
| FY2011 | Dec 31, 2011 | $4.59M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.76M | -48.9% |
| Q2 FY2026 | Jun 30, 2026 | $9.63M | -60.7% |
| Q1 FY2026 | Mar 31, 2026 | $10.75M | -66.6% |
| Q4 FY2025 | Dec 31, 2025 | $16.93M | -59.2% |
| Q3 FY2025 | Sep 30, 2025 | $17.13M | -49.4% |
| Q2 FY2025 | Jun 30, 2025 | $24.48M | -41.9% |
| Q1 FY2025 | Mar 31, 2025 | $32.16M | -27.5% |
| Q4 FY2024 | Dec 31, 2024 | $41.49M | -19.6% |
| Q3 FY2024 | Sep 30, 2024 | $33.84M | +41.1% |
| Q2 FY2024 | Jun 30, 2024 | $42.17M | +37.2% |
| Q1 FY2024 | Mar 31, 2024 | $44.38M | +18.9% |
| Q4 FY2023 | Dec 31, 2023 | $51.60M | +12.0% |
| Q3 FY2023 | Sep 30, 2023 | $23.99M | -62.0% |
| Q2 FY2023 | Jun 30, 2023 | $30.74M | -56.9% |
| Q1 FY2023 | Mar 31, 2023 | $37.33M | -44.2% |
| Q4 FY2022 | Dec 31, 2022 | $46.09M | -37.1% |
| Q3 FY2022 | Sep 30, 2022 | $63.17M | -5.9% |
| Q2 FY2022 | Jun 30, 2022 | $71.35M | -5.5% |
| Q1 FY2022 | Mar 31, 2022 | $66.95M | -8.6% |
| Q4 FY2021 | Dec 31, 2021 | $73.24M | +220.3% |
| Q3 FY2021 | Sep 30, 2021 | $67.14M | +193.7% |
| Q2 FY2021 | Jun 30, 2021 | $75.50M | +32.1% |
| Q1 FY2021 | Mar 31, 2021 | $73.24M | +7.6% |
| Q4 FY2020 | Dec 31, 2020 | $22.86M | -69.5% |
| Q3 FY2020 | Sep 30, 2020 | $22.86M | -60.9% |
| Q2 FY2020 | Jun 30, 2020 | $57.13M | -16.4% |
| Q1 FY2020 | Mar 31, 2020 | $68.05M | -8.4% |
| Q4 FY2019 | Dec 31, 2019 | $74.97M | -10.8% |
| Q3 FY2019 | Sep 30, 2019 | $58.48M | +18.8% |
| Q2 FY2019 | Jun 30, 2019 | $68.32M | +23.0% |
| Q1 FY2019 | Mar 31, 2019 | $74.31M | +17.9% |
| Q4 FY2018 | Dec 31, 2018 | $84.07M | +324.4% |
| Q3 FY2018 | Sep 30, 2018 | $49.23M | -40.0% |
| Q2 FY2018 | Jun 30, 2018 | $55.53M | -40.8% |
| Q1 FY2018 | Mar 31, 2018 | $63.03M | -40.7% |
| Q4 FY2017 | Dec 31, 2017 | $19.81M | -83.8% |
| Q3 FY2017 | Sep 30, 2017 | $82.03M | – |
| Q2 FY2017 | Jun 30, 2017 | $93.89M | – |
| Q1 FY2017 | Mar 31, 2017 | $106.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $122.54M | – |
See a number that looks wrong?